EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

AI ‐Based Analysis of Tumor‐Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025 ‐ A1 Study

Kohei Hamada iD, Junzo Hamanishi iD, Noriomi Matsumura iD, Akihiko Ueda iD, Shiro Takamatsu, Kosuke Yoshihara iD, Takayuki Nagasawa, Toshiyuki Seki, Akira Kikuchi, Etsuko Fujimoto, Mana Taki, Koji Yamanoi und 6 weitere

Cancer Science · 2026-11 · 117 (11) · 3160-3170

DOI: 10.1111/cas.70474 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Science, online erschienen am 10.07.2026. Verfasst von Kohei Hamada und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan. Hauptthemen laut MEDLINE: Lymphocytes, Tumor-Infiltrating, Ovarian Neoplasms, Artificial Intelligence, Homologous Recombination. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding the tumor immune microenvironment, especially tumor‐infiltrating lymphocytes (TILs), remains crucial in ovarian cancer. However, the distribution and prognostic significance of TILs across histological subtypes and genetic backgrounds remain unclear. As part of the JGOG3025‐A1 study, diagnostic slides from 400 cases were collected. Two artificial intelligence‐based cell classification models were used to evaluate the spatial distribution of TILs. The TIL score was calculated as the number of TILs divided by the analyzed area, and the immune‐inflamed group was defined based on TIL scores. Among histological subtypes, high‐grade serous carcinoma (HGSC) exhibited the highest TIL scores, clear cell carcinoma the lowest, and endometrioid carcinoma intermediate values. In HGSC, TIL scores did not significantly differ according to BRCA alteration or homologous recombination deficiency (HRD) status. The HRD/immune‐inflamed group had the most favorable prognosis. In the homologous recombination‐proficient population, the immune‐inflamed group had better progression‐free survival, whereas this trend did not appear for overall survival. In analyzes of the relationships between TIL levels and genomic structure, whole‐genome doubling was associated with lower TIL infiltration in HRD tumors but showed no association in HRP tumors. In conclusion, HGSC showed the highest amount of TIL infiltration among subtypes, and prognostic stratification can be achieved by integrating pathology‐based immunophenotypes and HRD status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphocytes, Tumor-InfiltratingOvarian NeoplasmsArtificial IntelligenceHomologous RecombinationHumansFemalePrognosisTumor MicroenvironmentMiddle AgedAgedCystadenocarcinoma, Serous

Stichwörter der Autor:innen

artificial intelligencedeep learningdigital pathologyovarian cancertumor‐infiltrating lymphocytes

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
  • Department of Obstetrics and Gynecology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osaka, Japan.
  • Department of Obstetrics and Gynecology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
  • Department of Obstetrics and Gynecology, Iwate Medical University, Iwate, Japan.
  • Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.

ORCID-Profile: Kohei Hamada, Junzo Hamanishi, Noriomi Matsumura, Akihiko Ueda, Kosuke Yoshihara, Ryusuke Murakami, Katsutoshi Oda, Muneaki Shimada

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Hamada, K., Hamanishi, J., Matsumura, N., Ueda, A., Takamatsu, S., Yoshihara, K., Nagasawa, T., Seki, T., Kikuchi, A., Fujimoto, E., Taki, M., Yamanoi, K., Murakami, R., Kudo, H., Oda, K., Shimada, M., Okamoto, A., & Mandai, M. (2026). AI ‐Based Analysis of Tumor‐Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025 ‐ A1 Study. Cancer Science, 117(11), 3160-3170. https://doi.org/10.1111/cas.70474

Vancouver

Hamada K, Hamanishi J, Matsumura N, Ueda A, Takamatsu S, Yoshihara K, et al. AI ‐Based Analysis of Tumor‐Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025 ‐ A1 Study. Cancer Science. 2026;117(11):3160-3170. doi:10.1111/cas.70474

BibTeX
@article{Hamada2026,
  author = {Hamada, Kohei and Hamanishi, Junzo and Matsumura, Noriomi and Ueda, Akihiko and Takamatsu, Shiro and Yoshihara, Kosuke and Nagasawa, Takayuki and Seki, Toshiyuki and Kikuchi, Akira and Fujimoto, Etsuko and Taki, Mana and Yamanoi, Koji and Murakami, Ryusuke and Kudo, Hisaaki and Oda, Katsutoshi and Shimada, Muneaki and Okamoto, Aikou and Mandai, Masaki},
  title = {AI ‐Based Analysis of Tumor‐Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025 ‐ A1 Study},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {11},
  pages = {3160--3170},
  doi = {10.1111/cas.70474}
}
Kostenlos starten →